Skip to content

13F-HR filed by BRAIDWELL LP

BRAIDWELL LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 81 holding rows worth $3,032,008,157.

Accession
0000905148-23-000454
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 81 entries on the cover page, a total value of $3,032,008,157 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,032,008,157 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC40131MAB5NOTE 11/1250,022,000$168,847,260dollars as filedprincipal
EXACT SCIENCES CORP30063PAC9NOTE 0.375% 3/0139,000,000$122,748,869dollars as filedprincipal
NANOSTRING TECHNOLOGIES INC63009RAD1BOND145,520,000$121,832,851dollars as filedprincipal
NOVOCURE LTD67011XAB9NOTE 11/0134,334,000$116,802,148dollars as filedprincipal
ALPHATEC HLDGS INC02081GAB8NOTE 0.750% 8/0101,250,000$108,210,938dollars as filedprincipal
BRIDGEBIO PHARMA INC10806XAB8NOTE 2.500% 3/1143,338,000$106,213,458dollars as filedprincipal
NEVRO CORP64157FAC7NOTE 2.750% 4/0109,251,000$102,695,940dollars as filedprincipal
GLAUKOS CORP COM377322102Stock1,806,651$90,513,215dollars as filed
IVERIC BIO INC46583P102COM3,714,672$90,377,970dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM766,800$77,615,496dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock2,137,110$76,487,167dollars as filed
ALIGN TECHNOLOGY INC COM016255101Stock207,130$69,210,418dollars as filed
BIOGEN INC COM09062X103Stock220,742$61,372,898dollars as filed
NEVRO CORP64157F103COM1,632,915$59,029,877dollars as filed
Intuitive Surgical,Inc.46120E602COM223,120$57,000,466dollars as filed
IRHYTHM HOLDINGS INC COM450056106Stock454,169$56,330,581dollars as filed
NATERA INC COM632307104Stock982,241$54,534,020dollars as filed
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/156,031,000$53,901,491dollars as filedprincipal
NUVASIVE INC670704AL9BOND51,500,000$51,148,812dollars as filedprincipal
KARYOPHARM THERAPEUTICS INC48576UAA4BOND65,976,000$51,148,346dollars as filedprincipal
DECIPHERA PHARMACEUTICALS IN24344T101COM3,241,351$50,078,873dollars as filed
VAXCYTE INC COM92243G108Stock1,319,978$49,472,775dollars as filed
IONIS PHARMACEUTICALS INC462222AD2NOTE 4/052,740,000$48,125,250dollars as filedprincipal
EXACT SCIENCES CORP30063PAB1NOTE 0.375% 3/148,300,000$45,183,667dollars as filedprincipal
ORTHOPEDIATRICS CORP68752L100COMMON STOCK998,871$44,239,997dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock3,159,895$42,247,796dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM1,038,310$41,989,256dollars as filed
AMYRIS INC03236MAJ0BOND137,850,000$39,080,475dollars as filedprincipal
Amgen Inc.031162100COM161,500$39,042,625dollars as filed
INSMED INC457669AA7NOTE 1.750% 1/139,963,000$36,486,219dollars as filedprincipal
NEOGENOMICS INC64049MAB6NOTE 0.250% 1/148,678,000$36,021,720dollars as filedprincipal
IONIS PHARMACEUTICALS INC462222AB6NOTE 0.125%12/136,533,000$33,800,477dollars as filedprincipal
NUVASIVE INC670704AJ4NOTE 0.375% 3/136,665,000$32,466,858dollars as filedprincipal
CRINETICS PHARMACEUTICALS INC COM22663K107Stock2,019,714$32,436,607dollars as filed
OUTSET MEDICAL INC690145107COM1,754,350$32,280,040dollars as filed
NEOGENOMICS INC64049MAA8Convertible Debt33,000,000$30,958,125dollars as filedprincipal
HARROW INC415858109COM1,452,538$30,735,704dollars as filed
PENUMBRA INC COM70975L107Stock107,044$29,832,092dollars as filed
BELLUS HEALTH INC NEW07987C204COM4,126,194$29,708,597dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS601,801$29,018,844dollars as filed
DICE THERAPEUTICS INC23345J104COM984,800$28,214,520dollars as filed
TRAVERE THERAPEUTICS INC89422GAA5CNV28,350,000$27,868,050dollars as filedprincipal
KRYSTAL BIOTECH INC COM501147102Stock348,036$27,863,762dollars as filed
Bridgebio Pharma Inc Note 2.250 percent 2/010806XAD4Convertible42,294,000$27,379,090dollars as filedprincipal
MERUS N VN5749R100COM1,473,084$27,104,746dollars as filed
HILLEVAX INC43157M102COM1,620,216$26,782,170dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock3,269,094$26,446,970dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock1,997,055$23,645,131dollars as filed
ANAPTYSBIO INC032724106COM973,073$21,174,068dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR426,110$21,066,878dollars as filed
DBV TECHNOLOGIES S A23306J101ADR12,107,785$20,462,157dollars as filed
ALECTOR INC014442107COMMON STOCK3,206,315$19,847,090dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM920,049$19,431,435dollars as filed
GLOBUS MED INC CL A379577208Stock335,200$18,985,728dollars as filed
PARAGON 28 INC69913P105COM1,098,722$18,755,185dollars as filed
STERIS PLC SHS USDG8473T100Stock95,694$18,304,348dollars as filed
MIRATI THERAPEUTICS INC60468T105COM452,000$16,805,360dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,945,134$16,222,418dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock1,377,872$15,873,085dollars as filed
INVITAE CORP46185LAB9NOTE 2.000% 9/016,781,000$14,842,012dollars as filedprincipal
VIR BIOTECHNOLOGY INC92764N102COM604,036$14,055,918dollars as filed
Mersana Therapeutics Inc59045L106Common Stock3,355,805$13,792,359dollars as filed
PULMONX CORP745848101COM1,163,294$13,005,627dollars as filed
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,097,300$12,706,734dollars as filed
COMPASS THERAPEUTICS INC20454B104COM3,247,847$10,620,460dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock333,800$10,284,378dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR24,600$9,165,468dollars as filed
AXONICS INC05465P101COM166,704$9,095,370dollars as filed
MINERALYS THERAPEUTICS INC603170101COM550,300$8,617,698dollars as filed
TRANSMEDICS GROUP INC89377M109COM98,459$7,456,300dollars as filed
NUVATION BIO INC COM CL A67080N101Stock4,122,900$6,844,014dollars as filed
SUPERNUS PHARMACEUTICALS868459AD0BOND6,500,000$6,515,368dollars as filedprincipal
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock648,451$5,725,822dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK1,249,900$5,649,548dollars as filed
INSMED INC457669AB5NOTE 0.750% 6/03,500,000$2,721,080dollars as filedprincipal
SILK ROAD MEDICAL INC82710M100COMMON STOCK63,331$2,478,142dollars as filed
IMMATICS N.VN44445109SHS322,287$2,223,780dollars as filed
ESPERION THERAPEUTICS INC NEW COM29664W105Stock1,211,519$1,926,315dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK73,665$1,300,924dollars as filed
ILLUMINA INC452327AK5NOTE 8/111,100,000$1,087,736dollars as filedprincipal
AVALO THERAPEUTICS INC COM NEW05338F207Stock247,254$432,695dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000905148-23-000454this filing2023-05-15acceptance time not in the bulk data set